Notably, lowering AFP cutoff values from the traditional 20 ng/mL to approximately 10–14 ng/mL improves sensitivity for HCC detection while maintaining comparable specificity, with the greatest benefit observed in patients with non-viral liver disease such as MASLD and alcohol-associated liver disease(ALD) [39,40,41]. Here, AFP is linked to hepatocellular carcinoma.